158 related articles for article (PubMed ID: 2939139)
1. Long-lasting deficit of functional T cell precursors in human bone marrow transplant recipients revealed by limiting dilution methods.
Rozans MK; Smith BR; Burakoff SJ; Miller RA
J Immunol; 1986 Jun; 136(11):4040-8. PubMed ID: 2939139
[TBL] [Abstract][Full Text] [Related]
2. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry.
Atkinson K
Bone Marrow Transplant; 1986 Dec; 1(2):121-32. PubMed ID: 2971408
[TBL] [Abstract][Full Text] [Related]
3. T cell repopulation from functionally restricted splenic progenitors: 10,000-fold expansion documented by using limiting dilution analyses.
Miller RA; Stutman O
J Immunol; 1984 Dec; 133(6):2925-32. PubMed ID: 6238091
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
5. Generation of CD8 cytolytic T cells early after autologous or allogeneic bone marrow transplantation.
Charmot D; Ragueneau M; Olive D; Maraninchi D; Mawas C
Bone Marrow Transplant; 1987 Aug; 2(2):183-94. PubMed ID: 2901879
[TBL] [Abstract][Full Text] [Related]
6. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
[TBL] [Abstract][Full Text] [Related]
7. Decreased hematopoietic accessory cell function following bone marrow transplantation.
Emerson SG; Sieff CA; Gross RG; Rozans MK; Miller RA; Rappeport JM; Nathan DG
Exp Hematol; 1987 Nov; 15(10):1013-21. PubMed ID: 2959495
[TBL] [Abstract][Full Text] [Related]
8. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
9. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and functional heterogeneity of human peripheral blood T lymphocytes producing colony stimulating factor. A clonal and precursor frequency analysis.
Pantaleo G; Moretta A; Cillo C; Eliason JF; Moretta L
J Immunol; 1985 Dec; 135(6):3933-7. PubMed ID: 3877760
[TBL] [Abstract][Full Text] [Related]
11. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
[TBL] [Abstract][Full Text] [Related]
12. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
13. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation.
Klingemann HG; Kohn FR; Phillips GL
Eur Cytokine Netw; 1991; 2(2):131-6. PubMed ID: 1813016
[TBL] [Abstract][Full Text] [Related]
14. T-cell phenotypic profile and colony formation during recovery from cytotoxic therapy-induced marrow aplasia.
Ashkenazi YJ; Barth KC; Elfenbein GJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6513-8. PubMed ID: 3933827
[TBL] [Abstract][Full Text] [Related]
15. Functional T cell deficits after bone marrow transplantation across minor histocompatibility barriers: effects of graft-vs-host disease on precursor frequency of reactive cells.
Ferrara JL; Daley JP; Burakoff SJ; Miller RA
J Immunol; 1987 Jun; 138(11):3598-603. PubMed ID: 3108369
[TBL] [Abstract][Full Text] [Related]
16. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
17. Inhibiton of IL 2 production after human allogeneic bone marrow transplantation.
Azogui O; Gluckman E; Fradelizi D
J Immunol; 1983 Sep; 131(3):1205-8. PubMed ID: 6224851
[TBL] [Abstract][Full Text] [Related]
18. Human bone marrow allograft recipients: production of, and responsiveness to, interleukin 2.
Warren HS; Atkinson K; Pembrey RG; Biggs JC
J Immunol; 1983 Oct; 131(4):1771-5. PubMed ID: 6352802
[TBL] [Abstract][Full Text] [Related]
19. A cell-saving non-radioactive limiting dilution analysis-assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequencies.
Bouma GJ; Schanz U; Oudshoorn M; van der Meer-Prins PM; Roelen DL; van Rood JJ; Claas FH
Bone Marrow Transplant; 1996 Jan; 17(1):19-23. PubMed ID: 8673049
[TBL] [Abstract][Full Text] [Related]
20. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
Thiele DL; Charley MR; Calomeni JA; Lipsky PE
J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
